travoprost ophthalmic solution 0.004%

DRUG4 trials

Sponsors

Allergan, Aerie Pharmaceuticals, Alcon Research

Conditions

Glaucoma, Open-AngleNormal Tension GlaucomaOcular HypertensionOpen Angle Glaucoma

Phase 2

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

CompletedNCT01789736

Aerie PharmaceuticalsOcular Hypertension, Open Angle Glaucoma

Start: 2013-02-28End: 2013-06-30Updated: 2014-03-17

Phase 4

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT01253902

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2010-12-31End: 2011-10-31Updated: 2012-11-07

Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction

CompletedNCT01547598

AllerganGlaucoma, Open-Angle, Ocular Hypertension

Start: 2011-12-31End: 2013-07-31Updated: 2014-08-15

Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma

CompletedNCT01995136

Alcon ResearchNormal Tension Glaucoma, Ocular Hypertension

Start: 2013-09-30End: 2014-06-30Updated: 2015-10-07

Related Papers

Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension

Current Medical Research and Opinion2013-09-0579 citations